Answers are grounded in this paper and cite their sources.
Background: The response to risperidone in patients with schizophrenia is influenced by many factors including the genetic ones.The innovations in biotechnology have provided essential tools for conduction of pharmacogenetic research and subsequently a number of pharmaco-dynamic and pharmaco-kinetic studies delineating the response of anti-psychotics in schizophrenia have been conducted till date.So, we may prevision that pharmaco-genetic knowledge can provide us with the tools to personalize treatment in routine psychiatric clinical practice. Purview of this article:This article is a narrative review of existing pharmaco-genetic research that has elicited relationship of various gene polymorphisms and response to risperidone monotherapy in patients with schizophrenia.The association of response to risperidone treatment and the genetic markers across the dopaminergic, serotonergic, and the metabolizing enzymes have been reported here.However, the pharmaco-kinetic aspects of the metabolizing enzymes and other genes are not reviewed in this paper.Conclusions: Some of the genes coding for dopaminergic and serotonergic receptors and their mutations have been shown to predict risperidone response.Certain promising observations have been made for the association of DRD2 receptor genes (Ser311Cys, -141C Ins/Del), DRD3 (Ser9Gly), 5-HTR2A genes (102T>C), and COMT genes.Although, some positive association with some other genes have also been found, but the evidence is minimal.Despite the availability of such evidence, it is limited for clinical utilization in its present form.However, efforts shall be made at further exploration of genetic underpinnings of schizophrenia, refinement of study methods, and discovery of newer biomarkers to attain utilization of pharmaco-genetics in clinical practice.
No takes yet. Share an insight, caveat, or question.
Jitender Aneja (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: